drugset / Trial / NCT06791187
A Study in Healthy People to Test Whether BI 1291583 Influences the Amount of Dabigatran in the Body
NaCrossoverOpen-labelTreatment
Summary
The main objective of this trial is to investigate the effect of a single dose of BI 1291583 on the pharmacokinetics of a single dose of dabigatran, an efflux transporter P-glycoprotein (P-gp) substrate.
Timeline
- Start
- 2025-01-23
- Primary completion
- 2025-02-21
- Completion
- 2025-03-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1291583 | Unknown | — | — |
| Subject | Dabigatran etexilate | Unknown | — | Oral |
Indications
No indication recorded.